Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Blocklisting Application

27 Dec 2012 13:22

RNS Number : 3818U
Oxford Catalysts Group PLC
27 December 2012
 



Oxford Catalysts Group PLC

("Oxford Catalysts" or the "Company" or the "Group")

 

Blocklisting Application

 

The Company announces that it has made a blocklisting application in respect of a total of 2,500,000 ordinary shares of 1p each ("Blocklisting Shares") to be admitted to trading on AIM.

 

The Blocklisting Shares will be used by the Company to satisfy the exercise of options by directors and employees of the Company under the Oxford Catalysts Group Share Option Scheme and pursuant to bonus schemes. It is expected that the Blocklisting Shares will be admitted to trading on AIM on or around 2 January 2013.

 

Blocklisting Shares will be issued credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares of the Company.

 

In addition, the Company announces that it has issued and allotted a total of 97,893 ordinary shares of 1p each (the "New Ordinary Shares") pursuant to the exercise of options under the Oxford Catalysts Group Share Option Scheme and issue of bonus shares. The New Ordinary Shares, which are being issued credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares of the Company, will be admitted to trading pursuant to the Blocklisting referred to above.

 

The total number of Ordinary Shares with voting rights in issue following the issue of the New Ordinary Shares will be 91,431,571. Oxford Catalysts does not hold any ordinary shares in treasury. The figure of 91,431,571 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Group under the Financial Services Authority's Disclosure and Transparency Rules.

 

 

For further information, please contact:

 

Oxford Catalysts

Roy Lipski, CEO

Susan Robertson, CFO

 

 

+44 (0)20 7831 3113

+1 614 733 3300

Cenkos Securities (Nomad and Joint Broker)

Ken Fleming

Neil McDonald

 

 

+44 (0)20 7397 8900 / +44 (0)131 220 9772

+44 (0)20 7397 8900 / +44 (0)131 220 9771

 

 

Notes to Editors

 

Oxford Catalysts enables modular Gas-to-Liquids ("GTL") plants to convert unconventional, remote and problem gas into valuable liquid fuels. Systems based on the Group's technology (marketed under the brand name Velocys) are significantly smaller than those using conventional technology, enabling modular plants that can be deployed cost effectively in remote locations and on smaller fields than is possible with competing systems. Together with world-class partners, Oxford Catalysts provides complete modular GTL solutions that address an untapped market of up to 25 million barrels of fuel a day.

 

Oxford Catalysts Group PLC is listed on the AIM market of the London Stock Exchange (LSE:OCG). The Group has some 85 employees with facilities near Oxford, UK and Columbus, Ohio, USA.

 

www.oxfordcatalysts.com 

www.velocys.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFVFILDFIF
Date   Source Headline
27th Dec 201912:02 pmRNSPrice Monitoring Extension
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
16th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20197:00 amRNSDirectorate Change
28th Nov 20194:40 pmRNSSecond Price Monitoring Extn
28th Nov 20194:35 pmRNSPrice Monitoring Extension
13th Nov 20197:00 amRNSVelocys fulfils order for bio-jet project in Japan
12th Nov 20191:00 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSLongspur Research initiates coverage on Velocys
15th Oct 20194:41 pmRNSSecond Price Monitoring Extn
15th Oct 20194:36 pmRNSPrice Monitoring Extension
10th Oct 20197:00 amRNSNegative-emission fuel agreement
7th Oct 20197:00 amRNSChange of Registered Office
24th Sep 20193:23 pmRNSTurner Pope investor evening
19th Sep 20197:00 amRNSVelocys secures order for biorefinery licence
18th Sep 20197:00 amRNSInterim results
5th Aug 20195:12 pmRNSHolding(s) in Company
5th Aug 20194:59 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSHolding(s) in Company
2nd Aug 20194:24 pmRNSHolding(s) in Company
2nd Aug 20199:00 amRNSDisclosure re Directors' Participation in Placing
31st Jul 201912:36 pmRNSResult of general meeting and total voting rights
15th Jul 20197:00 amRNSFundraise of £7M. Project co-funding by BA & Shell
4th Jul 20199:34 amRNSBlock listing Interim Review
12th Jun 20191:45 pmRNSResult of AGM
21st May 20197:00 amRNSMailing of 2018 annual report and AGM notice
21st May 20197:00 amRNSAnnual Financial Report
15th May 20197:00 amRNSFinal Results
29th Apr 20197:00 amRNSSuccessful close-out of ENVIA JV
27th Mar 20197:00 amRNSTransfer of FT Reactors to Velocys from ENVIA
11th Mar 20197:00 amRNSInsurance settlement reached for ENVIA incident
12th Feb 20197:00 amRNSAmended Agreement with Red Rock Biofuels
4th Jan 201910:29 amRNSBlock listing Interim Review
24th Dec 20187:00 amRNSDirectors' Shareholdings
19th Dec 20187:00 amRNSSite secured for UK waste-to-jet-fuel project
17th Dec 20187:00 amRNSAppointment of Non-Executive Directors
22nd Nov 20187:00 amRNSHolding(s) in Company
20th Nov 20187:00 amRNSHolding(s) in Company
20th Nov 20187:00 amRNSHolding(s) in Company
13th Nov 20188:04 amRNSDirectorate Changes - Appointment of CEO and CFO
5th Nov 20187:00 amRNSConversion of Convertible Loan Notes
16th Oct 20184:40 pmRNSSecond Price Monitoring Extn
16th Oct 20184:35 pmRNSPrice Monitoring Extension
15th Oct 20187:00 amRNSStatement re Share Price Movement
27th Sep 20184:40 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
26th Sep 20187:00 amRNSInterim Results
12th Sep 201812:04 pmRNSHolding(s) in Company
10th Sep 20187:00 amRNSENVIA plant update
6th Sep 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.